Key facts
- This page summarizes Juan C. Jaen's Form 4 filing for Arcus Biosciences, Inc. (RCUS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Jan 2026, 20:21.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.
Footnote F2
Includes the unvested portion of the Reporting Person's RSU grants.
Footnote F3
The option becomes exercisable in 48 equal monthly installments after January 1, 2026, subject to the Reporting Person's continued service to the Company.